The Latest Headlines at Riverton Roll
BioMarin Pharmaceutical (BMRN) Scheduled to Post Earnings on Wednesday
BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report) is scheduled to post its quarterly earnings results after the market closes on Wednesday, April 24th. Analysts expect BioMarin Pharmaceutical to post earnings of $0.60... More of this article »
Critical Contrast: Caravelle International Group (NASDAQ:CACO) versus OceanPal (NASDAQ:OP)
Caravelle International Group (NASDAQ:CACO – Get Free Report) and OceanPal (NASDAQ:OP – Get Free Report) are both small-cap business services companies, but which is the better business? We will contrast the two companies... More of this article »
Head-To-Head Contrast: Bank of America (NYSE:BAC) & Nicolet Bankshares (NYSE:NIC)
Bank of America (NYSE:BAC – Get Free Report) and Nicolet Bankshares (NYSE:NIC – Get Free Report) are both finance companies, but which is the superior investment? We will contrast the two businesses based on the strength... More of this article »
Reviewing Semler Scientific (NASDAQ:SMLR) and Pixie Dust Technologies (NASDAQ:PXDT)
Semler Scientific (NASDAQ:SMLR – Get Free Report) and Pixie Dust Technologies (NASDAQ:PXDT – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based... More of this article »
NeueHealth (NEUE) vs. Its Rivals Head to Head Review
NeueHealth (NYSE:NEUE – Get Free Report) is one of 14 public companies in the “Hospital & medical service plans” industry, but how does it contrast to its peers? We will compare NeueHealth to similar companies... More of this article »
Immunovant (NASDAQ:IMVT) versus Genocea Biosciences (NASDAQ:GNCAQ) Head-To-Head Comparison
Genocea Biosciences (NASDAQ:GNCAQ – Get Free Report) and Immunovant (NASDAQ:IMVT – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of... More of this article »
Analysts Set Glacier Bancorp, Inc. (NASDAQ:GBCI) Price Target at $37.80
Glacier Bancorp, Inc. (NASDAQ:GBCI – Get Free Report) has earned a consensus rating of “Moderate Buy” from the four ratings firms that are presently covering the stock, Marketbeat reports. Two research analysts have... More of this article »
Comparing Compass (NYSE:COMP) and X3 (NASDAQ:XTKG)
Compass (NYSE:COMP – Get Free Report) and X3 (NASDAQ:XTKG – Get Free Report) are both small-cap computer and technology companies, but which is the better business? We will compare the two companies based on the strength... More of this article »
Patterson-UTI Energy, Inc. (NASDAQ:PTEN) Given Consensus Rating of “Moderate Buy” by Brokerages
Shares of Patterson-UTI Energy, Inc. (NASDAQ:PTEN – Get Free Report) have been assigned an average rating of “Moderate Buy” from the thirteen research firms that are presently covering the stock, Marketbeat.com reports.... More of this article »
Centerspace (NYSE:CSR) Receives Consensus Rating of “Moderate Buy” from Analysts
Shares of Centerspace (NYSE:CSR – Get Free Report) have been given an average recommendation of “Moderate Buy” by the seven brokerages that are currently covering the firm, MarketBeat.com reports. Three equities... More of this article »
Zoomcar (NASDAQ:ZCAR) versus Getaround (NYSE:GETR) Head-To-Head Review
Getaround (NYSE:GETR – Get Free Report) and Zoomcar (NASDAQ:ZCAR – Get Free Report) are both small-cap business services companies, but which is the superior stock? We will compare the two businesses based on the strength... More of this article »
Research Solutions (NASDAQ:RSSS) and MultiPlan (NYSE:MPLN) Financial Review
MultiPlan (NYSE:MPLN – Get Free Report) and Research Solutions (NASDAQ:RSSS – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength... More of this article »
Biogen (BIIB) Scheduled to Post Quarterly Earnings on Wednesday
Biogen (NASDAQ:BIIB – Get Free Report) is scheduled to be issuing its quarterly earnings data before the market opens on Wednesday, April 24th. Analysts expect the company to announce earnings of $3.48 per share for the quarter.... More of this article »